Genscript Biotech Corporation (HKG:1548)

Hong Kong · Delayed Price · Currency is HKD

13.61

-0.24 (-1.73%)

Apr 27, 2026, 4:08 PM HKT

Revenue by Segment

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Operation Unit	66.07M	56.89M	53.15M	56.12M	9.59M
Operation Unit Growth	16.14%	7.02%	-5.29%	485.13%	23.61%
Eliminations	-75.31M	-66.05M	-58.13M	-71.64M	-24.03M
Life-Science Services and Products	522.13M	454.95M	412.91M	360.54M	315.79M
Life-Science Services and Products Growth	14.77%	10.18%	14.53%	14.17%	26.41%
Industrial Synthetic Biology Products	57.95M	53.69M	43.05M	38.66M	38.57M
Industrial Synthetic Biology Products Growth	7.95%	24.70%	11.35%	0.25%	33.42%
Biologics Development Services	388.69M	95.02M	109.49M	125.01M	81.35M
Biologics Development Services Growth	309.05%	-13.21%	-12.41%	53.67%	101.23%
Cell Therapy	-	-	-	117.01M	68.83M
Cell Therapy Growth	-	-	-	70.00%	-9.05%
Total	959.53M	594.49M	560.48M	625.70M	490.10M
Total Growth	61.40%	6.07%	-10.42%	27.67%	25.39%

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Mainland China	476.08M	176.88M	167.22M	166.75M	144.35M
Mainland China Growth	169.15%	5.78%	0.28%	15.52%	46.67%
The United States of America	293.00M	265.09M	252.45M	332.10M	246.23M
The United States of America Growth	10.53%	5.01%	-23.98%	34.87%	12.49%
Europe	104.55M	80.93M	69.29M	53.28M	43.40M
Europe Growth	29.18%	16.80%	30.04%	22.76%	26.70%
Asia Pacific (Excluding Mainland China)	58.97M	53.08M	53.23M	59.01M	42.39M
Asia Pacific (Excluding Mainland China) Growth	11.10%	-0.29%	-9.79%	39.22%	33.08%
Others	26.94M	18.50M	18.28M	14.56M	13.72M
Others Growth	45.56%	1.21%	25.61%	6.07%	84.51%
Total	959.53M	594.49M	560.48M	625.70M	490.10M
Total Growth	61.40%	6.07%	-10.42%	27.67%	25.39%

Source: S&P Global Market Intelligence.